Treatment Options for Acute Icteric Hepatitis

Acute icteric hepatitis is often accompanied by significantly elevated transaminase levels, which indicates a more severe degree of liver inflammation and necrosis. In such cases, medications with strong hepatoprotective and anti-inflammatory effects are recommended. For example, glycyrrhizin preparations have been widely used for their ability to reduce liver damage and control inflammation.

In addition to anti-inflammatory agents, drugs that help reduce bilirubin levels are also essential in the treatment plan. Medications such as S-adenosylmethionine (SAMe) and potassium magnesium aspartate are commonly prescribed to support liver function and alleviate jaundice symptoms.

If the cause of icteric hepatitis is related to biliary or intra-abdominal infections, antibiotic therapy should be considered as part of the treatment strategy. Similarly, in cases where the condition is triggered by an acute exacerbation of chronic hepatitis B with high viral load, antiviral therapy must be initiated alongside standard liver-protecting treatments.

For patients with severe jaundice that does not respond well to conventional medical interventions, and when bilirubin levels continue to rise despite treatment, plasma exchange therapy may be a necessary and life-saving option. This approach can help reduce toxin buildup and support liver recovery while the organ regenerates.

Overall, the treatment of acute icteric hepatitis should be tailored to the underlying cause and severity of the disease. Early diagnosis and a comprehensive therapeutic strategy are crucial for preventing progression to severe liver failure. Patients are advised to seek medical attention promptly and follow a treatment plan designed by a qualified healthcare professional.